308 related articles for article (PubMed ID: 20021666)
1. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.
Frank S
BMC Neurol; 2009 Dec; 9():62. PubMed ID: 20021666
[TBL] [Abstract][Full Text] [Related]
2. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
Huntington Study Group
Neurology; 2006 Feb; 66(3):366-72. PubMed ID: 16476934
[TBL] [Abstract][Full Text] [Related]
3. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J
Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979
[TBL] [Abstract][Full Text] [Related]
4. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
Chen JJ; Ondo WG; Dashtipour K; Swope DM
Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
[TBL] [Abstract][Full Text] [Related]
5. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
Frank S; Stamler D; Kayson E; Claassen DO; Colcher A; Davis C; Duker A; Eberly S; Elmer L; Furr-Stimming E; Gudesblatt M; Hunter C; Jankovic J; Kostyk SK; Kumar R; Loy C; Mallonee W; Oakes D; Scott BL; Sung V; Goldstein J; Vaughan C; Testa CM;
JAMA Neurol; 2017 Aug; 74(8):977-982. PubMed ID: 28692723
[TBL] [Abstract][Full Text] [Related]
6. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
; Frank S; Testa CM; Stamler D; Kayson E; Davis C; Edmondson MC; Kinel S; Leavitt B; Oakes D; O'Neill C; Vaughan C; Goldstein J; Herzog M; Snively V; Whaley J; Wong C; Suter G; Jankovic J; Jimenez-Shahed J; Hunter C; Claassen DO; Roman OC; Sung V; Smith J; Janicki S; Clouse R; Saint-Hilaire M; Hohler A; Turpin D; James RC; Rodriguez R; Rizer K; Anderson KE; Heller H; Carlson A; Criswell S; Racette BA; Revilla FJ; Nucifora F; Margolis RL; Ong M; Mendis T; Mendis N; Singer C; Quesada M; Paulsen JS; Brashers-Krug T; Miller A; Kerr J; Dubinsky RM; Gray C; Factor SA; Sperin E; Molho E; Eglow M; Evans S; Kumar R; Reeves C; Samii A; Chouinard S; Beland M; Scott BL; Hickey PT; Esmail S; Fung WL; Gibbons C; Qi L; Colcher A; Hackmyer C; McGarry A; Klos K; Gudesblatt M; Fafard L; Graffitti L; Schneider DP; Dhall R; Wojcieszek JM; LaFaver K; Duker A; Neefus E; Wilson-Perez H; Shprecher D; Wall P; Blindauer KA; Wheeler L; Boyd JT; Houston E; Farbman ES; Agarwal P; Eberly SW; Watts A; Tariot PN; Feigin A; Evans S; Beck C; Orme C; Edicola J; Christopher E
JAMA; 2016 Jul; 316(1):40-50. PubMed ID: 27380342
[TBL] [Abstract][Full Text] [Related]
7. Tetrabenazine treatment for Huntington's disease-associated chorea.
Ondo WG; Tintner R; Thomas M; Jankovic J
Clin Neuropharmacol; 2002; 25(6):300-2. PubMed ID: 12469001
[TBL] [Abstract][Full Text] [Related]
8. The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Frank S; Testa C; Edmondson MC; Goldstein J; Kayson E; Leavitt BR; Oakes D; O'Neill C; Vaughan C; Whaley J; Gross N; Gordon MF; Savola JM;
CNS Drugs; 2022 Nov; 36(11):1207-1216. PubMed ID: 36242718
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Furr Stimming E; Claassen DO; Kayson E; Goldstein J; Mehanna R; Zhang H; Liang GS; Haubenberger D;
Lancet Neurol; 2023 Jun; 22(6):494-504. PubMed ID: 37210099
[TBL] [Abstract][Full Text] [Related]
10. Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease.
Claassen DO; Carroll B; De Boer LM; Wu E; Ayyagari R; Gandhi S; Stamler D
J Clin Mov Disord; 2017; 4():3. PubMed ID: 28265459
[TBL] [Abstract][Full Text] [Related]
11. The long-term effect of tetrabenazine in the management of Huntington disease.
Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR
Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408
[TBL] [Abstract][Full Text] [Related]
12. Tetrabenazine: for chorea associated with Huntington's disease.
Scott LJ
CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
[TBL] [Abstract][Full Text] [Related]
13. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review.
Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW
J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
Setter SM; Neumiller JJ; Dobbins EK; Wood L; Clark J; DuVall CA; Santiago A
Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
Kenney C; Hunter C; Davidson A; Jankovic J
Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
[TBL] [Abstract][Full Text] [Related]
16. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
Jankovic J; Clarence-Smith K
Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
[TBL] [Abstract][Full Text] [Related]
17. Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Schultz JL; Killoran A; Nopoulos PC; Chabal CC; Moser DJ; Kamholz JA
Neurology; 2018 Jul; 91(3):e202-e207. PubMed ID: 29925548
[TBL] [Abstract][Full Text] [Related]
18. Real-World Experience With Deutetrabenazine for Huntington Disease Chorea.
Curtis K; Sung V
J Clin Pharmacol; 2024 Feb; 64(2):178-181. PubMed ID: 37565322
[TBL] [Abstract][Full Text] [Related]
19. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
Heo YA; Scott LJ
Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
[TBL] [Abstract][Full Text] [Related]
20. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.
Kegelmeyer DA; Kloos AD; Fritz NE; Fiumedora MM; White SE; Kostyk SK
J Neurol Sci; 2014 Dec; 347(1-2):219-23. PubMed ID: 25456459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
